Science & ResearchHybrid
Head of Platform Technologies MSAT Recombinant Mammalian Drug Substance CoE
SanofiFramingham, MA
$178,500–257,833.33/yr
Posted Oct 13, 2026
What you’d do
Lead the Platform Technologies team within Global MSAT for recombinant mammalian drug substance, connecting R&D and manufacturing. The role covers manufacturing support, lifecycle management, process robustness and yield improvement. Full time. Found on the employer's careers page on Oct 17, 2026. Apply through the link.
You’ll need
- Master's degree required (PhD preferred) in chemical, biological, sciences or engineering
- 10+ years biopharmaceutical industry experience
- 5+ years biologics drug substance process or technology development or manufacturing support
- Hands-on drug substance process development
Our summary of the listing. The full listing has the details.